TEQ — Terranueva Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Terranueva, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2013 September 30th | 2014 September 30th | 2015 September 30th | 2016 September 30th | 2017 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.566 | 2.27 | 0.387 | 0.371 | 0.9 |
| Operating Profit | -0.566 | -2.27 | -0.387 | -0.371 | -0.9 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.524 | -2.26 | -0.364 | -0.353 | -0.886 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.498 | -2.2 | -0.341 | -0.353 | -0.85 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.498 | -2.2 | -0.341 | -0.353 | -0.85 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.498 | -2.2 | -0.341 | -0.353 | -0.85 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.009 | -0.019 | -0.006 | -0.006 | -0.009 |
| Dividends per Share |